BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porcellato I, Brachelente C, De Paolis L, Menchetti L, Silvestri S, Sforna M, Vichi G, Iussich S, Mechelli L. FoxP3 and IDO in Canine Melanocytic Tumors. Vet Pathol 2019;56:189-99. [DOI: 10.1177/0300985818808530] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Withers SS, Sparger EE, Boudreaux B, Mason NJ. Utilizing Microbes to Treat Naturally Occurring Cancer in Veterinary Species. Curr Clin Micro Rpt 2019;6:200-12. [DOI: 10.1007/s40588-019-00130-7] [Reference Citation Analysis]
2 Costa VR, Soileau AM, Liu C, Moeller CE, Carossino M, Langohr IM, Withers SS. Exploring the association of intratumoral immune cell infiltrates with histopathologic grade in canine mast cell tumors. Research in Veterinary Science 2022. [DOI: 10.1016/j.rvsc.2022.04.005] [Reference Citation Analysis]
3 Knapp DW, Dhawan D, Ramos-Vara JA, Ratliff TL, Cresswell GM, Utturkar S, Sommer BC, Fulkerson CM, Hahn NM. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans. Front Oncol 2019;9:1493. [PMID: 32039002 DOI: 10.3389/fonc.2019.01493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
4 Porcellato I, Silvestri S, Sforna M, Banelli A, Lo Giudice A, Mechelli L, Brachelente C. Tumor-infiltrating lymphocytes (TILs) in feline melanocytic tumors: A preliminary investigation. Vet Immunol Immunopathol 2021;242:110337. [PMID: 34715601 DOI: 10.1016/j.vetimm.2021.110337] [Reference Citation Analysis]
5 Porcellato I, Sforna M, Lo Giudice A, Bossi I, Musi A, Tognoloni A, Chiaradia E, Mechelli L, Brachelente C. Tumor-Associated Macrophages in Canine Oral and Cutaneous Melanomas and Melanocytomas: Phenotypic and Prognostic Assessment. Front Vet Sci 2022;9:878949. [DOI: 10.3389/fvets.2022.878949] [Reference Citation Analysis]
6 Kim JH. Interleukin-8 in the Tumor Immune Niche: Lessons from Comparative Oncology. Adv Exp Med Biol 2020;1240:25-33. [PMID: 32060885 DOI: 10.1007/978-3-030-38315-2_2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Maeda S, Nakazawa M, Uchida M, Yoshitake R, Nakagawa T, Nishimura R, Miyamoto R, Bonkobara M, Yonezawa T, Momoi Y. Foxp3+ Regulatory T Cells Associated With CCL17/CCR4 Expression in Carcinomas of Dogs. Vet Pathol 2020;57:497-506. [PMID: 32347186 DOI: 10.1177/0300985820921535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Matsuda A, Hata A, Tanaka A, Matsuda H. Canine mast cell tumour cells regulate tryptophan catabolism via the expression of indoleamine 2,3-dioxygenase. Res Vet Sci 2021;137:159-62. [PMID: 33984619 DOI: 10.1016/j.rvsc.2021.04.030] [Reference Citation Analysis]
9 Porcellato I, Mecocci S, Mechelli L, Cappelli K, Brachelente C, Pepe M, Orlandi M, Gialletti R, Passeri B, Ferrari A, Modesto P, Ghelardi A, Razzuoli E. Equine Penile Squamous Cell Carcinomas as a Model for Human Disease: A Preliminary Investigation on Tumor Immune Microenvironment. Cells 2020;9:E2364. [PMID: 33121116 DOI: 10.3390/cells9112364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Omar NB, Bentley RT, Crossman DK, Foote JB, Koehler JW, Markert JM, Platt SR, Rissi DR, Shores A, Sorjonen D, Yanke AB, Gillespie GY, Chambers MR. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas. Neurosurg Focus 2021;50:E5. [PMID: 33524948 DOI: 10.3171/2020.11.FOCUS20844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Pi Castro D, José-López R, Fernández Flores F, Rabanal Prados RM, Mandara MT, Arús C, Pumarola Batlle M. Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes. J Neuropathol Exp Neurol 2020;79:184-93. [PMID: 31846038 DOI: 10.1093/jnen/nlz120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Porcellato I, Silvestri S, Menchetti L, Recupero F, Mechelli L, Sforna M, Iussich S, Bongiovanni L, Lepri E, Brachelente C. Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations. Vet Comp Oncol 2020;18:370-80. [PMID: 31750993 DOI: 10.1111/vco.12556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 Porcellato I, Brachelente C, Cappelli K, Menchetti L, Silvestri S, Sforna M, Mecocci S, Iussich S, Leonardi L, Mechelli L. FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors. Vet Pathol 2021;58:42-52. [PMID: 33021155 DOI: 10.1177/0300985820960131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dow S. A Role for Dogs in Advancing Cancer Immunotherapy Research. Front Immunol 2019;10:2935. [PMID: 32010120 DOI: 10.3389/fimmu.2019.02935] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
15 Silvestri S, Porcellato I, Mechelli L, Menchetti L, Iussich S, De Maria R, Sforna M, Bongiovanni L, Brachelente C. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis. Vet Pathol 2020;57:608-19. [PMID: 32578507 DOI: 10.1177/0300985820934385] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sforna M, Chiaradia E, Porcellato I, Silvestri S, Moretti G, Mechelli L, Brachelente C. Characterization of Primary Cultures of Normal and Neoplastic Canine Melanocytes. Animals (Basel) 2021;11:768. [PMID: 33802040 DOI: 10.3390/ani11030768] [Reference Citation Analysis]
17 Hardwick L. A Comparative View on Molecular Alterations and Potential Therapeutic Strategies for Canine Oral Melanoma. Vet Sci 2021;8:286. [PMID: 34822659 DOI: 10.3390/vetsci8110286] [Reference Citation Analysis]
18 Belluco S, Sammarco A, Sapin P, Lurier T, Marchal T. FOXP3, CD208, and CD206 Expression in Canine Cutaneous Histiocytoma. Vet Pathol 2020;57:599-607. [PMID: 32783525 DOI: 10.1177/0300985820941818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]